Emeritus Professor
Em.prof.dr. Ed Kuijper
Prof. dr. E.J. Kuijper is a medical doctor and emeritus Professor of Experimental Bacteriology. He obtained his PhD in 1989 on “Aeromonas-associated diarrhea in the Netherlands” at the University of Amsterdam, following a one-year research fellowship at the Centers for Disease Control and Prevention (CDC) in Atlanta. He held a position at Amsterdam UMC until 2002, where he developed a research line on human immune defense against meningococcal disease.
Prof. Kuijper previously served as Head of the Department of Experimental Microbiology and as Director of the National Reference Laboratory for Clostridioides difficile at Leiden University Medical Center (LUMC) and the National Institute for Public Health and the Environment (RIVM). In 2015, he co-founded the National Donor Feces Bank (NDFB) for patient treatment and, in 2017, the Center for Microbiota Analysis and Therapeutics (CMAT) at LUMC. Between 2018 and 2024, he also held a position at the RIVM in Bilthoven.
Prof. Kuijper and his research group have received numerous national and European grants supporting both fundamental and clinical research on C. difficile infections, microbiome studies and infections caused by multidrug-resistant bacteria in humans and animals. Epidemiological studies were conducted in close collaboration with RIVM and the European Centre for Disease Prevention and Control (ECDC).
He has authored more than 520 peer-reviewed publications and book chapters. Until 2016, Prof. Kuijper served as President of the “European Study Group on Clostridioides difficile (ESGCD)”. Since 2018, he developed and chaired the “ESCMID Study Group on Host and Microbiota Interactions (ESGHAMI).”
Publications
-
Towards optimising and standardising donor screening for faecal microbiota transplantion.
Liu CS, Merrick B, Taboun ZS, Mullish BH, Goldenberg SD, Terveer EM, Porcari S, Bradbury RS, Ianiro G, Ng SC; Donor Screening Working Group; Kao D, Kuijper E.
Gut. 2025 Dec 4:gutjnl-2025-336532
-
Gut colonisation by extended-spectrum β-lactamase-producing Escherichia coli and its association with the gut microbiome and metabolome in Dutch adults: a matched case-control study.
Ducarmon QR, Zwittink RD, Willems RPJ, Verhoeven A, Nooij S, van der Klis FRM, Franz E, Kool J, Giera M, Vandenbroucke-Grauls CMJE, Fuentes S, Kuijper EJ.
Lancet Microbe. 2022 Jun;3(6):e443-e451.
-
Clostridium difficile infection in Europe: a hospital-based survey.
Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, ECDIS Study Group.
Lancet. 2011 Jan 1;377(9759):63-73.
Groups:
Experimental Bacteriology
